InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Browse the complete record of transactions filed by Blackman Samuel C., Directeur Médical. Insider active across 1 companies, notably Day One Biopharmaceuticals, Inc.. Cumulatively, 5 filings have been logged. Total volume traded: €977k. The latest transaction was disclosed on 15 June 2022 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations5 total
€777,67750,000 shares@ €15.55350.081% mcap79.6% of flow
Common Stock
SEC:0001209191-22-038229:0·
€99,4196,672 shares@ €14.9009100.0% of flow
Common Stock
SEC:0001209191-22-002026·
€99,4196,672 shares@ €14.90090.010% mcap10.2% of flow
Common Stock
SEC:0001209191-22-002026:0·
01,000,000 shares0
Common Stock
SEC:0001209191-21-068000·
01,000,000 shares0
Common Stock
SEC:0001209191-21-068000:0·
5 of 5 declarations
About Blackman Samuel C.
Samuel C. Blackman is the Chief Medical Officer at Day One Biopharmaceuticals, Inc. He is responsible for the medical direction of the company, overseeing research and development initiatives. His expertise in the medical field is essential for guiding drug development projects and ensuring regulatory compliance.
